Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
01/09/2008 | CN100360519C Benzothiepine ileal bile acid transport inhibitors |
01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
01/08/2008 | US7317102 Diarylmethyl and related compounds |
01/08/2008 | US7317034 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
01/08/2008 | US7317033 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
01/08/2008 | US7317032 Imidazolyl inhibitors of 15-lipoxygenase |
01/08/2008 | US7317031 3-(SO2-substituted anilino)-5-amino-1-((hetero)aryl-carbonyl- or sulfonyl)-1H-1,2,4-triazoles: 4-[[5-amino-1-[(3-methyl-2-thienyl)carbonyl]-1H-1,2,4-triazol-3-yl]amino]-benzenesulfonamide; for treating melanoma; cervical, ovarian and prostate adenocarcinoma; colon carcinoma and breast cancer |
01/08/2008 | US7317025 Non-peptidic NPY Y2 receptor inhibitors |
01/08/2008 | US7317022 3-isopropyl-2-oxo-2,3-dihydrobenzoimidazole-1-carboxylic acid [(1S,3R,5R)-8-((S)-2-hydroxy-3-methylamino-propyl)-8-azabicyclo[3.2.1]oct-3-yl]-amide; bioavailability upon oral administration; medical conditions mediated by 5-HT4 receptor activity |
01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
01/08/2008 | CA2172513C Aminocyclohexylesters and uses thereof |
01/03/2008 | WO2008002974A1 Pyrrole derivatives and their methods of use |
01/03/2008 | WO2008001931A2 Fused cyclic compounds |
01/03/2008 | WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
01/03/2008 | WO2008000407A1 Inhibitors of cxcr2 |
01/03/2008 | WO2007125331A3 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
01/03/2008 | WO2007120729A3 Pyridyl amide t-type calcium channel antagonists |
01/03/2008 | WO2007113005A3 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors |
01/03/2008 | WO2007089626A3 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof |
01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
01/03/2008 | US20080004288 Indazole Sulphonamide Derivatives |
01/03/2008 | US20080004275 Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds |
01/03/2008 | US20080004245 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
01/03/2008 | CA2658362A1 Metalloprotease inhibitors |
01/03/2008 | CA2656003A1 Fused cyclic compounds |
01/03/2008 | CA2647601A1 Pyrrole derivatives and their methods of use |
01/02/2008 | EP1873144A1 Fused heterocyclic compound |
01/02/2008 | EP1871766A1 Antifungal triazole derivatives |
01/02/2008 | EP1871759A1 Benzodioxane and benzodioxolane derivatives and uses thereof |
01/02/2008 | EP1871746A1 Substituted n-[ypyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
01/02/2008 | EP1871374A2 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
01/02/2008 | EP1474422B1 R-(-)-1-¬2-(7-CHLOROBENZO-¬B -THIOPHEN-3-Yl-METHOXY)-2-(2,4-DICHLOROPHENYL)ETHYL -1H-IMIDAZOLE |
01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
01/02/2008 | CN101099286A Method and installation means for installing an electrical machine |
01/02/2008 | CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative |
01/02/2008 | CN101098857A Nitro indazole derivatives |
01/02/2008 | CN101098855A 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
01/02/2008 | CN100358877C Process for preparation of fungicidal compositions |
01/02/2008 | CN100358870C Aminotetralin derivatives as muscarinic receptor antagonists |
01/01/2008 | USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
01/01/2008 | US7314938 Immune and/or inflammatory disorders; autoimmune disorders; disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1); antagonize CD11/CD18 receptors associated with leukocytes. |
01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
01/01/2008 | US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases |
01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
01/01/2008 | US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo |
01/01/2008 | US7314870 Compounds, their preparation and use |
12/27/2007 | WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition |
12/27/2007 | WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof |
12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |
12/27/2007 | WO2007149105A2 Fluorescein based sensors for tracking nitric oxide in live cells |
12/27/2007 | WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
12/27/2007 | WO2007148774A1 Cyclic amine compound |
12/27/2007 | WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
12/27/2007 | WO2007147841A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
12/27/2007 | WO2007147778A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
12/27/2007 | WO2007120284A3 Glucagon receptor antagonists, preparation and therapeutic uses |
12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
12/27/2007 | US20070299264 Method to control insects resistant to common insecticides |
12/27/2007 | US20070299125 Substituted indoles |
12/27/2007 | US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders |
12/27/2007 | US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
12/27/2007 | US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors |
12/27/2007 | US20070299073 Imidazolyl derivatives |
12/27/2007 | US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity |
12/27/2007 | US20070299056 Benzazepine derivatives for the treatment of neurological disorders |
12/27/2007 | US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
12/27/2007 | US20070297976 Metal Ion-Labeled Bis-Aminoethanethiol-Targeting Ligand Conjugates, Compositions, and Methods for Tissue-Specific Imaging |
12/27/2007 | US20070295398 Conducting Polymers With Porphyrin Cross-Linkers |
12/27/2007 | CA2657967A1 Cyclopentane derivatives as antiglaucoma agents |
12/27/2007 | CA2657213A1 Peptide epoxyketones for proteasome inhibition |
12/27/2007 | CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof |
12/27/2007 | CA2654689A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
12/27/2007 | CA2652859A1 Pyrazinones as cellular proliferation inhibitors |
12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
12/26/2007 | EP1869040A1 Dna-pk inhibitors |
12/26/2007 | EP1869026A1 Novel compounds |
12/26/2007 | EP1869025A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
12/26/2007 | EP1869024A1 New tricyclic angiotensin ii agonists |
12/26/2007 | EP1869023A1 New tricyclic angiotensin ii agonists |
12/26/2007 | EP1869021A1 Dna-pk inhibitors |
12/26/2007 | EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors |
12/26/2007 | EP1869010A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
12/26/2007 | EP1869009A1 New bicyclic angiotensin ii agonists |
12/26/2007 | EP1869008A1 Inhibitors of prolyl endopeptidase |
12/26/2007 | EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
12/26/2007 | EP1869002A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
12/26/2007 | EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
12/26/2007 | EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors |